Agent for high-grade NMIBC meets primary endpoint in phase III trial Interview with Colin P. N. Dinney, MD   Choosing treatment for hormone-sensitive PCa: Key questions Interview with Christopher Sweeney, MBBS Watch video interviews ADVERTISEMENT ADVERTISEMENT